Test Price
2,800 AEDโ Home Collection Available
PRPH2 Gene Choroidal Dystrophy, Central Areolar Type 2 (CACD2) Genetic Test in UAE | 2800 AED | DHA Licensed Facility
Executive Summary & Core Metrics
Price: 2,800 AED
Turnaround Time: 3โ4 Weeks
Accuracy: 99.9% Sensitivity (ISO 9001:2015 Certified)
Sample Collection: VIP Mobile Phlebotomy & Cold-Chain Home Collection (8 AM โ 11 PM Daily)
Clinical Guidance: Post-result telephonic interpretation with board-certified geneticist
Insurance Verification: Direct check via WhatsApp +971545488731
DHA Facility License: 1143
Laboratory: DNA Labs UAE
Test Overview & Methodology
This advanced genetic test identifies mutations in the PRPH2 gene responsible for Central Areolar Choroidal Dystrophy Type 2 (CACD2). It utilizes Next-Generation Sequencing (NGS) to analyze all coding regions, splice sites, and copy number variations, providing high diagnostic accuracy for affected individuals and their families.
| Feature | Our Test (NGS) | Standard Single-Gene Sanger Sequencing |
|---|---|---|
| Precision & Sensitivity | >99.9% for all PRPH2 variants including deep intronic regions | ~95% for known coding mutations only |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Methodology | NGS with CNV analysis | Targeted Sanger sequencing, limited CNV detection |
| Global Accreditation | ISO 9001:2015 (INT/EGQ/2509DA/3139) | Often regional only |
Physician Insight & Safety Protocols
โThe PRPH2 genetic test empowers families with early knowledge of inherited retinal disease risk. However, it should always be paired with regular ophthalmic monitoring and prompt evaluation for any changes in central vision.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA License: 9294403)
Medication and Treatment Advisory
โ ๏ธ Do not discontinue any prescribed medication or eye treatment without explicit consultation with your physician. Genetic results do not replace immediate ophthalmic care.
Exclusion Criteria & Emergency Red Flags
- Home Phlebotomy Exclusion: Uncontrolled bleeding disorders, current high-grade fever, or inability to provide informed consent. We reserve the right to postpone collection for patient safety.
- Red Flags โ Seek Immediate Emergency Care:
- Sudden painless loss of central vision.
- Rapid progression of dark or missing areas in the visual field.
- Severe eye pain, redness, or photophobia.
Patient FAQ & Clinical Guidance
1. What exactly does the PRPH2 genetic test detect?
Snippet: This test identifies mutations in the PRPH2 gene that cause central areolar choroidal dystrophy type 2, enabling accurate diagnosis and family risk assessment.
Through comprehensive Next-Generation Sequencing, we analyze all coding regions and splice sites of the PRPH2 gene to detect pathogenic variants, including single nucleotide variants, small insertions/deletions, and copy number changes. This information helps confirm a clinical suspicion of CACD2 and guides genetic counseling for at-risk relatives.
2. How is the sample collected and how long until results?
Snippet: A simple blood draw is taken during a VIP home collection, with results delivered within 3 to 4 weeks.
Our laboratory offers hospital-grade home phlebotomy across all UAE emirates from 8 AM to 11 PM. Samples are transported in validated cold-chain conditions to maintain DNA integrity. Once received, NGS processing and bioinformatics analysis require approximately 3โ4 weeks for a final, clinically validated report.
3. What do I do after receiving my test results?
Snippet: Every result includes a post-test teleconsultation with a clinical geneticist to explain findings and coordinate further eye care.
You will receive a secure electronic report. Our genetic counselor then schedules a telephonic session to interpret the results in the context of your family history and current eye health. For actionable mutations, direct referral pathways to UAE-based retinal specialists and ophthalmology centers are available. Regular follow-up with your ophthalmologist remains essential.
UAE Regulatory & Data Privacy Adherence
Data Privacy: All genetic data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Results are handled confidentially and shared only with the ordering physician and patient upon verified consent.
Clinical & Logistical Metadata
| Test Name | PRPH2 Gene Choroidal Dystrophy, Central Areolar Type 2 (CACD2) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | H31.21 |
| LOINC Code | 84842-8 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians